Core Laboratories EBIT Margin 2010-2025 | CLB
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Core Laboratories (CLB) over the last 10 years. The current EBIT profit margin for Core Laboratories as of March 31, 2025 is .
Core Laboratories EBIT Margin Historical Data |
Date |
TTM Revenue |
TTM EBIT |
EBIT Margin |
2025-03-31 |
$0.52B |
$0.05B |
10.42% |
2024-12-31 |
$0.52B |
$0.06B |
11.26% |
2024-09-30 |
$0.52B |
$0.06B |
11.47% |
2024-06-30 |
$0.51B |
$0.06B |
10.70% |
2024-03-31 |
$0.51B |
$0.06B |
11.35% |
2023-12-31 |
$0.51B |
$0.06B |
10.81% |
2023-09-30 |
$0.51B |
$0.06B |
11.00% |
2023-06-30 |
$0.51B |
$0.06B |
10.98% |
2023-03-31 |
$0.50B |
$0.05B |
9.74% |
2022-12-31 |
$0.49B |
$0.04B |
8.78% |
2022-09-30 |
$0.49B |
$0.04B |
8.42% |
2022-06-30 |
$0.48B |
$0.03B |
6.89% |
2022-03-31 |
$0.48B |
$0.03B |
7.13% |
2021-12-31 |
$0.47B |
$0.05B |
9.79% |
2021-09-30 |
$0.46B |
$0.06B |
11.98% |
2021-06-30 |
$0.45B |
$0.06B |
13.23% |
2021-03-31 |
$0.44B |
$0.04B |
9.71% |
2020-12-31 |
$0.49B |
$-0.08B |
-16.02% |
2020-09-30 |
$0.53B |
$-0.08B |
-15.09% |
2020-06-30 |
$0.60B |
$-0.06B |
-10.03% |
2020-03-31 |
$0.65B |
$-0.03B |
-4.45% |
2019-12-31 |
$0.67B |
$0.10B |
14.37% |
2019-09-30 |
$0.68B |
$0.09B |
13.60% |
2019-06-30 |
$0.69B |
$0.10B |
14.00% |
2019-03-31 |
$0.70B |
$0.10B |
14.59% |
2018-12-31 |
$0.70B |
$0.12B |
16.86% |
2018-09-30 |
$0.70B |
$0.13B |
18.94% |
2018-06-30 |
$0.68B |
$0.12B |
18.29% |
2018-03-31 |
$0.66B |
$0.12B |
17.85% |
2017-12-31 |
$0.65B |
$0.11B |
16.98% |
2017-09-30 |
$0.62B |
$0.10B |
16.21% |
2017-06-30 |
$0.60B |
$0.10B |
15.75% |
2017-03-31 |
$0.59B |
$0.09B |
14.84% |
2016-12-31 |
$0.59B |
$0.09B |
14.75% |
2016-09-30 |
$0.63B |
$0.09B |
14.01% |
2016-06-30 |
$0.68B |
$0.11B |
16.72% |
2016-03-31 |
$0.74B |
$0.14B |
19.24% |
2015-12-31 |
$0.80B |
$0.16B |
20.30% |
2015-09-30 |
$0.89B |
$0.23B |
25.50% |
2015-06-30 |
$0.97B |
$0.27B |
27.75% |
2015-03-31 |
$1.04B |
$0.31B |
29.51% |
2014-12-31 |
$1.09B |
$0.35B |
31.86% |
2014-09-30 |
$1.08B |
$0.34B |
31.76% |
2014-06-30 |
$1.08B |
$0.34B |
31.48% |
2014-03-31 |
$1.08B |
$0.34B |
31.44% |
2013-12-31 |
$1.07B |
$0.33B |
31.13% |
2013-09-30 |
$1.05B |
$0.32B |
30.64% |
2013-06-30 |
$1.02B |
$0.31B |
30.50% |
2013-03-31 |
$1.01B |
$0.30B |
29.99% |
2012-12-31 |
$0.98B |
$0.30B |
30.31% |
2012-09-30 |
$0.97B |
$0.29B |
30.31% |
2012-06-30 |
$0.96B |
$0.28B |
29.60% |
2012-03-31 |
$0.94B |
$0.27B |
28.77% |
2011-12-31 |
$0.91B |
$0.25B |
27.64% |
2011-09-30 |
$0.87B |
$0.24B |
27.52% |
2011-06-30 |
$0.84B |
$0.24B |
28.10% |
2011-03-31 |
$0.81B |
$0.23B |
28.54% |
2010-12-31 |
$0.79B |
$0.23B |
28.59% |
2010-09-30 |
$0.77B |
$0.21B |
27.21% |
2010-06-30 |
$0.74B |
$0.19B |
26.19% |
2010-03-31 |
$0.71B |
$0.19B |
27.09% |
2009-12-31 |
$0.70B |
$0.19B |
26.87% |
Sector |
Industry |
Market Cap |
Revenue |
Oils/Energy |
Oil & Gas - Field Services |
$0.544B |
$0.524B |
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry principally in the United States, Canada and internationally. Core Laboratories Inc., formerly known as CORE LABS NV, is based in Houston, Texas.
|